These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28649898)

  • 1. A review of body composition and pharmacokinetics in oncology.
    Hopkins JJ; Sawyer MB
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):947-956. PubMed ID: 28649898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of cancer muscle mass loss on anticancer treatment toxicities].
    Chemama S; Raynard B; Antoun S
    Bull Cancer; 2016 Sep; 103(9):786-93. PubMed ID: 27206822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments.
    Hopkins JJ; Sawyer MB
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):1-29. PubMed ID: 29876640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
    Hilmi M; Jouinot A; Burns R; Pigneur F; Mounier R; Gondin J; Neuzillet C; Goldwasser F
    Pharmacol Ther; 2019 Apr; 196():135-159. PubMed ID: 30521882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.
    Antoun S; Borget I; Lanoy E
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):383-9. PubMed ID: 24189893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of nutritional status in cancer--the relationship between body composition and pharmacokinetics.
    Prado CM; Maia YL; Ormsbee M; Sawyer MB; Baracos VE
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1197-203. PubMed ID: 23919745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
    Drami I; Pring ET; Gould L; Malietzis G; Naghibi M; Athanasiou T; Glynne-Jones R; Jenkins JT
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e540-e552. PubMed ID: 34147322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
    Tan BH; Brammer K; Randhawa N; Welch NT; Parsons SL; James EJ; Catton JA
    Eur J Surg Oncol; 2015 Mar; 41(3):333-8. PubMed ID: 25498359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
    Pappalardo G; Almeida A; Ravasco P
    Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
    Griggs JJ; Mangu PB; Anderson H; Balaban EP; Dignam JJ; Hryniuk WM; Morrison VA; Pini TM; Runowicz CD; Rosner GL; Shayne M; Sparreboom A; Sucheston LE; Lyman GH;
    J Clin Oncol; 2012 May; 30(13):1553-61. PubMed ID: 22473167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients.
    Wong AL; Seng KY; Ong EM; Wang LZ; Oscar H; Cordero MT; Copones R; Fan L; Tan SH; Goh BC; Lee SC
    Breast Cancer Res Treat; 2014 Feb; 144(1):143-52. PubMed ID: 24481679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis.
    Purcell SA; Elliott SA; Kroenke CH; Sawyer MB; Prado CM
    Curr Oncol Rep; 2016 Feb; 18(2):8. PubMed ID: 26769113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
    Prado CM; Cushen SJ; Orsso CE; Ryan AM
    Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
    Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
    Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
    Hunter RJ; Navo MA; Thaker PH; Bodurka DC; Wolf JK; Smith JA
    Cancer Treat Rev; 2009 Feb; 35(1):69-78. PubMed ID: 18922643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of lean body mass in the oncologic patient.
    Tsai S
    Nutr Clin Pract; 2012 Oct; 27(5):593-8. PubMed ID: 22898746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.
    Gérard S; Bréchemier D; Lefort A; Lozano S; Abellan Van Kan G; Filleron T; Mourey L; Bernard-Marty C; Rougé-Bugat ME; Soler V; Vellas B; Cesari M; Rolland Y; Balardy L
    J Nutr Health Aging; 2016; 20(8):878-888. PubMed ID: 27709238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.
    Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ
    Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
    Jastaniah W; Aseeri M
    J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.